Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy

Cardioprotective Effects of Telmisartan against Heart Failure in Rats Induced By Experimental Autoimmune Myocarditis through the Modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor Axis

(2012) Vijayakumar Sukumaran et al.   International Journal of Biological Sciences

ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1

(2012) Akihiro Shimizu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury

(2012) Lívia Corrêa Barroso et al.   International Journal of Hypertension

Regulation of angiotensin-(1–7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure

(2011) Wen-na Zong et al.   ACTA PHARMACOLOGICA SINICA

Telmisartan acts through the modulation of ACE-2/ANG 1–7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis

(2011) Vijayakumar Sukumaran et al.   LIFE SCIENCES

PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na+-ATPase

(2010) Lucienne S. Lara et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats

(2010) Kátia D. da Silveira et al.   CLINICAL SCIENCE

Angiotensin-(1–7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy

(2010) Elena Velkoska et al.   CLINICAL SCIENCE

Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities

(2010) Gursev S. Dhaunsi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent

(2010) Taiji Matsusaka et al.   HYPERTENSION

Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis

(2010) K. D. da Silveira et al.   JOURNAL OF IMMUNOLOGY

Adriamycin nephropathy: A model of focal segmental glomerulosclerosis

(2010) VINCENT WS LEE et al.   NEPHROLOGY

Angiotensin (1−7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice

(2009) Yiwen Li et al.   HYPERTENSION RESEARCH

Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria

(2009) Sérgio V.B. Pinheiro et al.   KIDNEY INTERNATIONAL

Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells

(2009) E. Gava et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation

(2009) Vanesa Esteban et al.   PLoS One

Angiotensin-(1-7) and Its Effects in the Kidney

(2009) Marc Dilauro et al.   TheScientificWorldJOURNAL

Chronic angiotensin (17) injection accelerates STZ-induced diabetic renal injury1

(2008) Ying SHAO et al.   ACTA PHARMACOLOGICA SINICA

Angiotensin-(1-7) as an antihypertensive, antifibrotic target

(2008) Michael J. Katovich et al.   CURRENT HYPERTENSION REPORTS

Angiotensin receptor blockers: RAAS blockade and renoprotection

(2008) Luis M. Ruilope   CURRENT MEDICAL RESEARCH AND OPINION

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis

(2008) Robson A. S. Santos et al.   EXPERIMENTAL PHYSIOLOGY

Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan

(2008) N. Mihailovic-Stanojevic et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION